Dr Salman Razvi
Dr Yaasir Mamoojee
| Clinical Impact of New Reference Intervals for the Roche Prolactin II Immunoassay | 2025 |
|
Dr Richard Quinton
Dr Rachel Boal
Dr Claire Wood
Professor Timothy Cheetham
Dr Yaasir Mamoojee
et al. | Optimal Uterine Growth During Pubertal Induction in Hypogonadal Females Is Dependent on Type and Duration of Unopposed Oestrogen Treatment | 2025 |
|
Sophie Howarth
Dr Richard Quinton
Dr Yaasir Mamoojee
| An unusual phenocopy for postmenopausal ovarian hyperandrogenism: LH-driven testosterone secretion by adrenal adenoma expressing luteinising hormone-chorionic gonadotrophin receptor | 2024 |
|
Richard Bliss
Dr Yaasir Mamoojee
| Clinical outcomes from surgical management of primary aldosteronism based on inconclusive adrenal vein sampling | 2024 |
|
Dr Bridget Griffiths
Dr Alice Lorenzi
Dr Ben Thompson
Dr Yaasir Mamoojee
| Diagnostic accuracy of morning serum cortisol concentration in confirming recovery of the hypothalamic-pituitary-adrenal axis in patients on chronic glucocorticoid therapy | 2024 |
|
Professor Timothy Cheetham
Dr Yaasir Mamoojee
Dr Richard Quinton
| Gonadotropin treatment of cryptorchidism in congenital hypogonadotropic hypogonadism—Age is no limit? | 2024 |
|
Dr Yaasir Mamoojee
Dr Richard Quinton
| Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs | 2024 |
|
Dr Yaasir Mamoojee
| Value of cannulated prolactin testing in identifying true hyperprolactinaemia in females of reproductive age | 2024 |
|
Dr Richard Quinton
Dr Petros Perros
Professor Simon Pearce
Dr Catherine Napier
Dr Earn Gan
et al. | Levothyroxine absorption test: A therapeutic strategy for improving medication adherence | 2023 |
|
Richard Bliss
Dr Richard Quinton
Dr Yaasir Mamoojee
| Subtyping primary aldosteronism by inconclusive adrenal vein sampling | 2023 |
|
Dr Catherine Napier
Dr Earn Gan
Dr Anna Mitchell
Dr Andy James
Dr Yaasir Mamoojee
et al. | Residual Adrenal Function in Autoimmune Addison's Disease-Effect of Dual Therapy With Rituximab and Depot Tetracosactide | 2020 |
|
